Jump to:
loading...| Preferred Name |
Betrixaban |
|
| Synonyms |
|
|
| Definitions |
An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Betrixaban is primarily excreted unchanged in the bile and has a half life of about 19 hours. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C75154 |
|
| Accepted_Therapeutic_Use_For |
prophylaxis of venous thromboembolism (VTE) |
|
| CAS_Registry |
330942-05-7 |
|
| Chemical_Formula |
C23H22ClN5O3 |
|
| code |
C75154 |
|
| Contributing_Source |
CTRP FDA |
|
| definition |
An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Betrixaban is primarily excreted unchanged in the bile and has a half life of about 19 hours. |
|
| Display_Name |
Betrixaban |
|
| FDA_UNII_Code |
74RWP7W0J9 |
|
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
| label |
Betrixaban |
|
| Legacy Concept Name |
Betrixaban |
|
| Preferred_Name |
Betrixaban |
|
| prefixIRI |
NCIT:C75154 |
|
| prefLabel |
Betrixaban |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C2698385 |
|
| subClassOf |
Create mapping